Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
14.12
+0.28 (2.02%)
Aug 18, 2026, 3:58 PM EST
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $55.44 billion as of August 19, 2026. Its market cap has increased by 78.19% in one year.
Market Cap
55.44B
Enterprise Value
94.20B
Revenue
51.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
$14.12
ChartMarket Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 55.44B, an increase of 846.08%. That is a compound annual growth rate of 6.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 55.44B | 29.62% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 826.07M |
| Veradigm | 534.05M |
| Nika Pharmaceuticals | 441.70M |
| American Oncology Network | 411.53M |
| Elite Pharmaceuticals | 333.90M |
| Northwest Biotherapeutics | 324.11M |
| CytoDyn | 260.45M |
| Comjoyful International Company | 211.51M |